Gomal Journal of Medical Sciences, published by GOMAL MEDICAL COLL, serves as a vital platform for disseminating research across diverse fields within Medicine, Microbiology, and Pharmacy. As an Open Access journal since 2013, it ensures that all research findings are freely accessible to the global scientific community, promoting wider engagement and collaboration. Based in Pakistan, the journal has been indexed in Scopus and has achieved notable ranks within its categories, reflecting its commitment to quality research despite its current quartile positioning at Q4. With an objective to advance knowledge and contribute to the improvement of health sciences, the Gomal Journal of Medical Sciences encourages submissions from researchers and practitioners striving to share innovative ideas and findings. Its unique context and contribution to the regional medical field make it an indispensable resource for students, scholars, and professionals committed to advancing medical science.

Asian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.

Turkish Journal of Medical Sciences is a distinguished peer-reviewed journal published by the Tubitak Scientific & Technological Research Council Turkey. With its commitment to advancing the field of medicine, the journal has established itself as a key resource for the dissemination of high-quality research from 1994 to 2024. Operating out of Turkey, it is recognized for its significant contributions, reflected in its impressive Scopus ranking, placing it in the top 18% of general medicine publications. The journal, classified in the Q3 quartile for miscellaneous medicine, provides an essential platform for researchers, professionals, and students interested in both innovative and foundational medical science. Although it does not currently offer open access, the journal remains influential in promoting the dissemination of vital medical research and fostering scholarly communication within the global medical community. By bridging local insights with international research trends, the Turkish Journal of Medical Sciences plays a crucial role in contributing to the advancement of health sciences.

Clinical and Experimental Medicine is a leading journal published by Springer-Verlag Italia SRL, dedicated to advancing the understanding of the intricate relationships between biomedical research and clinical applications. Since its inception in 2001, the journal has garnered an esteemed reputation, achieving Q1 quartile rankings in 2023 in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Medicine (miscellaneous), establishing itself as a key resource for researchers and practitioners alike. With an impactful contribution reflected in its Scopus rankings, particularly a #81/221 rank in the General Biochemistry, Genetics and Molecular Biology category, Clinical and Experimental Medicine serves as a rich platform for peer-reviewed articles that bridge theory and practice across diverse medical disciplines. The journal embraces Open Access options, broadening the accessibility of groundbreaking research to a global audience, thereby fostering collaboration and innovation. Located in Milan, Italy, it continually endeavors to enrich knowledge and share valuable insights essential for the advancement of health sciences.

Pulmonary Circulation is a leading open-access journal published by Wiley, focused on advancing the field of pulmonary and respiratory medicine. Established in 2011, the journal has garnered a prestigious reputation, achieving a Q2 ranking in 2023 among its category and ranking #70 out of 155 in Scopus within the specialty of Medicine – Pulmonary and Respiratory Medicine, reflecting its growing influence and relevance in the scientific community. With its commitment to delivering high-quality, peer-reviewed research, Pulmonary Circulation serves as a vital resource for researchers, clinicians, and students seeking to explore innovative ideas and findings in lung health, pulmonary vascular diseases, and therapeutic approaches. The journal has been open access since 2017, ensuring that groundbreaking research is accessible to a wider audience, thus promoting collaboration and knowledge exchange in this dynamic field. Located in the heart of the United States at 111 River St, Hoboken, NJ 07030-5774, the journal is dedicated to fostering advancements in pulmonary health and addressing real-world challenges facing patients globally.

BioMedicine-Taiwan, published by DIGITAL COMMONS BEPRESS, stands as a prominent open-access journal that has been disseminating vital research since 2014. With an ISSN of 2211-8020 and E-ISSN 2211-8039, this journal covers a wide array of disciplines within the biomedical field, reaching researchers and professionals keen on exploring cutting-edge advancements and innovative approaches in biochemistry, genetics, and general medicine. Notably categorized as Q2 in Biochemistry, Genetics and Molecular Biology and Q3 in Medicine for 2023, BioMedicine-Taiwan ranks well in its respective fields, reflecting its commitment to enhancing scholarly communication and knowledge dissemination. Situated in Taiwan, its impact is further highlighted by its Scopus rankings—placing it in the 70th percentile for general medicine and 47th percentile for general biochemistry and molecular biology, showcasing its significance in ongoing biomedical discourse. Researchers, students, and professionals are invited to engage with this invaluable resource to explore the latest findings and developments that shape the future of healthcare and biological sciences.

ACTA MEDICA OKAYAMA is a respected peer-reviewed journal published by Okayama University Medical School, dedicated to advancing knowledge in the fields of biochemistry, genetics, and general medicine. Established in 1972, this journal serves as a vital platform for researchers, professionals, and students to disseminate their findings and engage with ongoing scientific discussions. Based in Japan, it holds notable rankings within its categories, including Q3 in Biochemistry, Genetics and Molecular Biology (miscellaneous) and Q4 in Medicine (miscellaneous), indicating its emerging influence in a competitive field. Although it currently does not provide open access options, the journal strives to ensure high-quality and impactful research is accessible to a wide audience, contributing to both the regional and international academic landscape. With convergence of research until the year 2024, ACTA MEDICA OKAYAMA is poised to play an increasingly significant role in the evolution of medical and biological sciences.

Istanbul Medical Journal is a prominent open-access journal published by GALENOS PUBL HOUSE, dedicated to disseminating high-quality research in the field of medicine since its inception in 1994. The journal, identifiable by its ISSN 2619-9793 and E-ISSN 2148-094X, serves as a critical platform for healthcare professionals, researchers, and students who aim to share innovative studies and advancements within diverse medical domains. Its commitment to open access ensures that crucial findings and discussions are readily available to a global audience, fostering collaboration and knowledge exchange among the scientific community. Located in Istanbul, Türkiye, the journal not only contributes to the medical literature landscape but also emphasizes the importance of accessibility in research, aligning with current academic trends that prioritize the transmission of knowledge across barriers. As a resource for those involved in healthcare and medical research, the Istanbul Medical Journal plays a vital role in shaping future developments in medicine.

Byulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.

International Journal of Clinical and Experimental Medicine, an esteemed publication by E-CENTURY PUBLISHING CORP, serves as a vital resource for researchers and professionals in the fields of biochemistry, genetics, and molecular biology. Since its inception in 2009 and continuing until 2017, the journal has presented a wealth of knowledge aimed at fostering innovation and collaboration within the scientific community. Although the coverage has been discontinued in Scopus, the journal has established itself within the academic discourse, evidenced by its ranking in the 28th percentile for General Biochemistry, Genetics and Molecular Biology. As an open-access publication, it ensures widespread dissemination of research findings, making it a crucial platform for the advancement of clinical and experimental medicine. With its commitment to high-quality peer-reviewed articles, the International Journal of Clinical and Experimental Medicine remains a significant contribution to the body of knowledge in its field, serving as an invaluable tool for students, researchers, and practitioners alike.